Rhythm Pharmaceuticals buy Canaccord Genuity Group Inc.
Start price
02.03.23
/
50%
€21.20
Target price
02.03.24
€52.93
Performance (%)
85.85%
End price
03.03.24
€39.40
Summary
This prediction ended on 03.03.24 with a price of €39.40. With a performance of 85.85% the BUY prediction by Canaccord_Genuity_Gr was a big success. Canaccord_Genuity_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Rhythm Pharmaceuticals | -4.188% | -4.188% | 72.154% |
| iShares Core DAX® | 0.323% | 2.208% | 21.610% |
| iShares Nasdaq 100 | 0.145% | -0.987% | 5.603% |
| iShares Nikkei 225® | 0.091% | -1.421% | 12.897% |
| iShares S&P 500 | 0.371% | -0.469% | 3.470% |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) had its price target raised by analysts at Canaccord Genuity Group Inc. from $52.00 to $56.00. They now have a "buy" rating on the stock.
Ratings data for RYTM provided by MarketBeat
In the thread Trading Rhythm Pharmaceuticals
Die von Canaccord_Genuity_Gr gewählte maximale Laufzeit wurde überschritten